Cardamom (Elettaria cardamomum) essential oil significantly inhibits vascular cell adhesion molecule 1 and impacts genome-wide gene expression in human dermal fibroblasts-Reference-Cited by-同舟云学术

Cardamom (Elettaria cardamomum) essential oil significantly inhibits vascular cell adhesion molecule 1 and impacts genome-wide gene expression in human dermal fibroblasts

Published:2017-01-01 Issue:1 Volume:4 Page:1308066
ISSN:2331-205X
Container-title:Cogent Medicine
language:en
Short-container-title:Cogent Medicine

Author:

Han Xuesheng¹^ORCID,Parker Tory L.¹

Affiliation:

1. R&D, dōTERRA International, LLC, 389 South 1300 West, Pleasant Grove, UT 84062, USA

Publisher

Informa UK Limited

Subject

Applied Psychology,General Biochemistry, Genetics and Molecular Biology

Link

https://www.cogentoa.com/article/10.1080/2331205X.2017.1308066.pdf

Reference25 articles.

1. Fumigant Toxicity and Oviposition Deterrency of the Essential Oil from Cardamom,Elettaria cardamomum, Against Three Stored—product Insects

2. PHARMACOLOGICAL STUDIES OF CARDAMOM OIL IN ANIMALS

3. A re-annotation pipeline for Illumina BeadArrays: improving the interpretation of gene expression data

4. Inhaled 1,8-Cineole Reduces Inflammatory Parameters in Airways of Ovalbumin-Challenged Guinea Pigs

5. Chemical target and pathway toxicity mechanisms defined in primary human cell systems

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Immunology - Ayurveda Perspective;Current Traditional Medicine;2024-10

2. Protective Role of Phenolic Compounds from Whole Cardamom (Elettaria cardamomum (L.) Maton) against LPS-Induced Inflammation in Colon and Macrophage Cells;Nutrients;2023-06-29

3. Plants with Immunomodulatory Potential Described in Ayurveda;Bioprospecting of Tropical Medicinal Plants;2023

4. Essential oils as potential skin antiinflammatory agent and their mechanisms of action;Studies in Natural Product Chemistry;2023

5. Middle Eastern Diets as a Potential Source of Immunomodulators;Plants and Phytomolecules for Immunomodulation;2022